Indonesia Health Minister Accused Of Corruption In X-ray Buy Not Questioned
This article was originally published in PharmAsia News
Executive SummaryIndonesia's health minister accused of graft in procuring X-ray machines for the nation's health system has yet to be questioned by the Anti-Corruption Commission (KPK) that made the allegations. A KPK spokesman said it is too early still to call Minister Siti Fadilah Supari for an interview because private companies are still being investigated. He said she is believed to have cost the country more than $400,000 because of significant price mark-ups associated with the purchase in 2007. The KPK also has alleged other violations. (Click here for more
You may also be interested in...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January 2020.
Industry experts expect a continued uptick in deals valued between $2bn-$10bn this year as buyers look to add critical mass in areas like oncology, rare disease and cell and gene therapy. Divestitures to free up capital and narrow focus should continue too.
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.